Related Experiment Videos
Factor VII survival studies in factor VII Padua abnormality
Acta Haematologica
|January 1, 1980
Summary
Two patients with a rare factor VII Padua abnormality received prophylactic factor VII concentrate for dental surgery. Successful hemostasis was achieved, demonstrating the efficacy of factor VII concentrates in managing bleeding risks.
Area of Science:
- Hematology
- Coagulation Disorders
Background:
- Factor VII Padua abnormality is a rare inherited bleeding disorder.
- Management of bleeding in such patients requires careful consideration of hemostatic agents.
Observation:
- Two patients with factor VII Padua abnormality underwent tooth extractions.
- Prophylactic administration of factor VII concentrates was employed prior to the procedures.
Findings:
- Factor VII concentrate doses of 15.8 and 17.2 units/kg were administered over 20-30 minutes.
- Achieved peak factor VII activity levels were 55% and 64%.
- Exogenous factor VII survival times were approximately 6-6.5 hours, with satisfactory hemostasis achieved in both cases.
Implications:
- Prophylactic factor VII concentrate administration is effective in preventing excessive bleeding during invasive procedures in patients with factor VII Padua abnormality.
- This approach ensures adequate hemostasis and reduces the risk of complications associated with bleeding disorders.